These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trends in hematopoietic stem cell transplant activity in Lebanon. Bazarbachi A, Zahreddine A, Massoud R, El Cheikh J, Hanna C, Nasr F, Abboud M, Ibrahim A. Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):315-320. PubMed ID: 28641098 [Abstract] [Full Text] [Related]
3. Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM. Bone Marrow Transplant; 2004 May; 33(10):1049-56. PubMed ID: 15048143 [Abstract] [Full Text] [Related]
4. Advances in pediatric hematopoietic stem cell transplantation. Barfield RC, Kasow KA, Hale GA. Cancer Biol Ther; 2008 Oct; 7(10):1533-9. PubMed ID: 18927494 [Abstract] [Full Text] [Related]
5. Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation. Georges GE, Storb R. Int J Hematol; 2003 Jan; 77(1):3-14. PubMed ID: 12568294 [Abstract] [Full Text] [Related]
6. Haematopoietic stem cell transplantation in South Africa: Current limitations and future perspectives. Grobbelaar S, Mercier AE, Verburgh E, Brittain D, Pepper MS. S Afr Med J; 2019 Sep 10; 109(8b):46-52. PubMed ID: 31662149 [Abstract] [Full Text] [Related]
7. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations. Atilla E, Ataca Atilla P, Demirer T. Balkan Med J; 2017 Jan 10; 34(1):1-9. PubMed ID: 28251017 [Abstract] [Full Text] [Related]
8. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner. Bogaert DJ, Laureys G, Naesens L, Mazure D, De Bruyne M, Hsu AP, Bordon V, Wouters E, Tavernier SJ, Lambrecht BN, De Baere E, Haerynck F, Kerre T. Br J Haematol; 2020 Mar 10; 188(5):768-773. PubMed ID: 31710708 [Abstract] [Full Text] [Related]
9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May 10; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in congenital disorders: A single-center experience. Faraci M, Giardino S, Bagnasco F, Morreale G, Terranova MP, Di Martino D, Lanino E. Pediatr Transplant; 2017 Sep 10; 21(6):. PubMed ID: 28649784 [Abstract] [Full Text] [Related]
15. Emerging concepts in haematopoietic cell transplantation. Li HW, Sykes M. Nat Rev Immunol; 2012 May 25; 12(6):403-16. PubMed ID: 22627859 [Abstract] [Full Text] [Related]
16. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review]. Zhang Z, Li X. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug 25; 16(4):969-74. PubMed ID: 18718102 [Abstract] [Full Text] [Related]
17. [Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies]. Yuan X, Sun ZM, Liu HL, Geng LQ, Wang ZY, Tong J, Yao W. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun 25; 16(3):614-7. PubMed ID: 18549640 [Abstract] [Full Text] [Related]
18. Haematopoietic stem cell transplantation for autoimmune disorders. Saccardi R, Di Gioia M, Bosi A. Curr Opin Hematol; 2008 Nov 25; 15(6):594-600. PubMed ID: 18832930 [Abstract] [Full Text] [Related]